Literature DB >> 7138769

Assessing completeness of cancer registration in the north-western region of England by a method of independent comparison.

U Nwene, A Smith.   

Abstract

Incompleteness of ascertainment of new cases of any disease leads to underestimation of its incidence rate and may result in false assumptions about incidence trends if incompleteness varies over the course of time (Fraser et al., 1978). We report an attempt to assess the completeness of ascertainment in a cancer registry in the North-Western Region of England using a method based on independent comparison with accurate morbidity data. A total of 1955 verified cases of cancer from 5 independent sources covering 11 sites were used in the study. The corrected mean level of overall registration completeness was found to be 94% but this varied appreciably with site and source of data. Independent comparison is recommended as an effective method for estimating the completeness of cancer registration.

Entities:  

Mesh:

Year:  1982        PMID: 7138769      PMCID: PMC2011182          DOI: 10.1038/bjc.1982.248

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  4 in total

1.  Death certificate data as an indication of the presence of certain common diseases at death.

Authors:  J H Abramson; M I Sacks; E Cahana
Journal:  J Chronic Dis       Date:  1971-09

2.  Cancer mortality in Europe, 1970--1974.

Authors:  H Hansluwka
Journal:  World Health Stat Q       Date:  1978

3.  Incidence of myeloid leukaemia in Lancashire.

Authors:  C G Geary; R T Benn; I Leck
Journal:  Lancet       Date:  1979-09-15       Impact factor: 79.321

4.  Methods of classifying and ascertaining children's tumours.

Authors:  I Leck; J M Birch; H B Marsden; J K Steward
Journal:  Br J Cancer       Date:  1976-07       Impact factor: 7.640

  4 in total
  19 in total

1.  Reliability of data of the Thames cancer registry on 673 cases of colorectal cancer: effect of the registration process.

Authors:  A M Pollock; N Vickers
Journal:  Qual Health Care       Date:  1995-09

2.  Concordance on the recording of cancer in the Saskatchewan Cancer Agency Registry, hospital charts and death registrations.

Authors:  N S Rawson; D L Robson
Journal:  Can J Public Health       Date:  2000 Sep-Oct

3.  Cancer in young people in the north of England, 1968-85: analysis by census wards.

Authors:  A W Craft; L Parker; S Openshaw; M Charlton; J Newell; J M Birch; V Blair
Journal:  J Epidemiol Community Health       Date:  1993-04       Impact factor: 3.710

4.  Establishing baseline data in cancer registration in northern England: implications for Health of the Nation targets.

Authors:  M Kardara; S Acquilla; D Forster; C McCarthy; J Stevenson
Journal:  J Epidemiol Community Health       Date:  1995-04       Impact factor: 3.710

5.  Cancer registration by linking pathology and district PAS data.

Authors:  B W Codling; D Pheby; D L Hagen; M F Duffin
Journal:  Br J Cancer       Date:  1990-08       Impact factor: 7.640

6.  Completeness of cancer and death follow-up obtained through the National Health Service Central Register for England and Wales.

Authors:  M M Hawkins; A J Swerdlow
Journal:  Br J Cancer       Date:  1992-08       Impact factor: 7.640

7.  The completeness of cancer registration in England: an assessment from the Oxford-FPA contraceptive study.

Authors:  L Villard-Mackintosh; M P Coleman; M P Vessey
Journal:  Br J Cancer       Date:  1988-10       Impact factor: 7.640

8.  Multiple primary tumours in a population-based series of patients with histopathologically peer-reviewed sarcomas.

Authors:  A L Hartley; V Blair; M Harris; J M Birch; S S Banerjee; A J Freemont; J McClure; L J McWilliam
Journal:  Br J Cancer       Date:  1993-12       Impact factor: 7.640

9.  The reliability of Cancer Registry records.

Authors:  M C Gulliford; J Bell; H M Bourne; A Petruckevitch
Journal:  Br J Cancer       Date:  1993-04       Impact factor: 7.640

10.  Completeness of cancer registration in England and Wales: an assessment based on 2,145 patients with Hodgkin's disease independently registered by the British National Lymphoma Investigation.

Authors:  A J Swerdlow; A J Douglas; G Vaughan Hudson; B Vaughan Hudson
Journal:  Br J Cancer       Date:  1993-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.